Showing results (31-40 of 157) with videos related to
Sort By:
Pageof 16
Immunological Reviews|July 11, 2008
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeuticsMarc Feldmann, Sir Ravinder N MainiImmunological Reviews|November 18, 2004
Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation?Evangelos Andreakos, Brian Foxwell, Marc FeldmannTherapeutic Advances in Musculoskeletal Disease|October 2, 2015
Towards an understanding of the role of DNA methylation in rheumatoid arthritis: therapeutic and diagnostic implicationsAdam Cribbs, Marc Feldmann, Udo OppermannJAMA Oncology|October 9, 2015
Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer StageDavid G Pfister, David M Rubin, Elena B Elkin, et al.Arthritis and Rheumatism|March 13, 2003
Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune responseClaudia Mauri, Marc Feldmann, Richard O WilliamsNature Reviews. Rheumatology|July 8, 2016
Macrophage heterogeneity in the context of rheumatoid arthritisIrina A Udalova, Alberto Mantovani, Marc FeldmannCurrent Opinion in Biotechnology|December 17, 2002
Monoclonal antibodies in immune and inflammatory diseasesEvangelos Andreakos, Peter C Taylor, Marc FeldmannCytokine|February 12, 2013
RelB/p50 regulates TNF production in LPS-stimulated dendritic cells and macrophagesChiara Gasparini, Brian M Foxwell, Marc FeldmannCurrent Opinion in Pharmacology|July 14, 2007
Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseasesRichard O Williams, Ewa Paleolog, Marc FeldmannCurrent Opinion in Biotechnology|November 25, 2004
Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseasesPeter C Taylor, Richard O Williams, Marc FeldmannPageof 16